Advertisement
Screener

Dimension Therapeutics, Inc. Share-based Payment Arrangement, Expense

Dimension Therapeutics, Inc. Share-based Payment Arrangement, Expense

Dimension Therapeutics, Inc. reported Share-based Payment Arrangement, Expense of $707.00 thousand for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-11-06.

Discontinued › Expense Statement › Operating Expenses

us-gaap:AllocatedShareBasedCompensationExpense · last filed 2017-11-06

  • Dimension Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2017-09-30 was $707.00K, a 33.24% decline year-over-year.
  • Dimension Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2017-06-30 was $864.00K, a 8.41% increase year-over-year.
  • Dimension Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2017-03-31 was $1.04M, a 95.12% increase year-over-year.
  • Dimension Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2016-12-31 was $978.00K, a 118.79% increase year-over-year.
  • Dimension Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2016 was $3.37M, a 152.59% increase from fiscal 2015.
  • Dimension Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2015 was $1.33M, a 1450.00% increase from fiscal 2014.
  • Dimension Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2014 was $86.00K.
Period endShare-based Payment Arrangement, Expense 3 monthShare-based Payment Arrangement, Expense 6 monthShare-based Payment Arrangement, Expense 9 monthShare-based Payment Arrangement, Expense 12 month
2017-09-30$707.00K
10-Q · filed 2017-11-06
$1.57M
derived: sum of 2 quarters · filed 2017-11-06
$2.61M
10-Q · filed 2017-11-06
$3.59M
derived: sum of 4 quarters · filed 2017-11-06
2017-06-30$864.00K
10-Q · filed 2017-08-08
$1.90M
10-Q · filed 2017-08-08
$2.88M
derived: sum of 3 quarters · filed 2017-08-08
$3.94M
derived: sum of 4 quarters · filed 2017-11-06
2017-03-31$1.04M
10-Q · filed 2017-05-10
$2.02M
derived: sum of 2 quarters · filed 2017-05-10
$3.08M
derived: sum of 3 quarters · filed 2017-11-06
$3.87M
derived: sum of 4 quarters · filed 2017-11-06
2016-12-31$978.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09
$2.04M
derived: sum of 2 quarters · filed 2017-11-06
$2.83M
derived: sum of 3 quarters · filed 2017-11-06
$3.37M
10-K · filed 2017-03-09
2016-09-30$1.06M
10-Q · filed 2017-11-06
$1.86M
derived: sum of 2 quarters · filed 2017-11-06
$2.39M
10-Q · filed 2017-11-06
$2.84M
derived: sum of 4 quarters · filed 2017-11-06
2016-06-30$797.00K
10-Q · filed 2017-08-08
$1.33M
10-Q · filed 2017-08-08
$1.78M
derived: sum of 3 quarters · filed 2017-08-08
$2.33M
derived: sum of 4 quarters · filed 2017-08-08
2016-03-31$533.00K
10-Q · filed 2017-05-10
$980.00K
derived: sum of 2 quarters · filed 2017-05-10
$1.53M
derived: sum of 3 quarters · filed 2017-05-10
$1.79M
derived: sum of 4 quarters · filed 2017-05-10
2015-12-31$447.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09
$997.00K
derived: sum of 2 quarters · filed 2017-03-09
$1.26M
derived: sum of 3 quarters · filed 2017-03-09
$1.33M
10-K · filed 2017-03-09
2015-09-30$550.00K
10-Q · filed 2016-11-10
$809.00K
derived: sum of 2 quarters · filed 2016-11-10
$886.00K
10-Q · filed 2016-11-10
$923.00K
derived: sum of 4 quarters · filed 2017-03-09
2015-06-30$259.00K
10-Q · filed 2016-08-11
$336.00K
10-Q · filed 2016-08-11
$373.00K
derived: sum of 3 quarters · filed 2017-03-09
$396.00K
derived: sum of 4 quarters · filed 2017-03-09
2015-03-31$77.00K
10-Q · filed 2016-05-12
$114.00K
derived: sum of 2 quarters · filed 2017-03-09
$137.00K
derived: sum of 3 quarters · filed 2017-03-09
2014-12-31$37.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09
$60.00K
derived: sum of 2 quarters · filed 2017-03-09
$86.00K
10-K · filed 2017-03-09
2014-09-30$23.00K
10-Q · filed 2015-12-04
$49.00K
10-Q · filed 2015-12-04
2013-12-31$4.00K
10-K · filed 2016-03-24